Literature DB >> 19608655

Functional characterization of wild-type and mutated pendrin (SLC26A4), the anion transporter involved in Pendred syndrome.

Silvia Dossena1, Simona Rodighiero, Valeria Vezzoli, Charity Nofziger, Elisabetta Salvioni, Marta Boccazzi, Elisabeth Grabmayer, Guido Bottà, Giuliano Meyer, Laura Fugazzola, Paolo Beck-Peccoz, Markus Paulmichl.   

Abstract

Pendred syndrome (PS) is the most frequent form of genetically related syndromic hearing loss, and is associated with mutations of pendrin, encoded by the SLC26A4 gene. This protein localizes to the cellular membrane and permits the exchange of anions between the cytosol and extracellular space. In the inner ear, pendrin conditions the endolymph, allowing for the proper function of sensory cells. Understanding the relationship between the genotype and phenotype of pendrin mutations would aid clinicians to better serve PS patients-however, little is known. Here, we summarize the available data concerning SLC26A4 mutations and how they relate to transporter function. The main findings suggest that all the truncation mutations tested annihilate pendrin function, and that the addition or omission of proline, or the addition or omission of charged amino acids in the sequence of SLC26A4 result in a substantial to dramatic reduction in pendrin function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608655     DOI: 10.1677/JME-08-0175

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  31 in total

1.  Engineered pendrin protein, an anion transporter and molecular motor.

Authors:  Jie Tang; Jason L Pecka; Xiaodong Tan; Kirk W Beisel; David Z Z He
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

2.  From zebrafish to mammal: functional evolution of prestin, the motor protein of cochlear outer hair cells.

Authors:  Xiaodong Tan; Jason L Pecka; Jie Tang; Oseremen E Okoruwa; Qian Zhang; Kirk W Beisel; David Z Z He
Journal:  J Neurophysiol       Date:  2010-11-03       Impact factor: 2.714

Review 3.  Molecular mechanisms and regulation of urinary acidification.

Authors:  Ira Kurtz
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

4.  Calcium oxalate stone formation in the inner ear as a result of an Slc26a4 mutation.

Authors:  Amiel A Dror; Yael Politi; Hashem Shahin; Danielle R Lenz; Silvia Dossena; Charity Nofziger; Helmut Fuchs; Martin Hrabé de Angelis; Markus Paulmichl; Steve Weiner; Karen B Avraham
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

5.  Developmental expression of solute carrier family 26A member 4 (SLC26A4/pendrin) during amelogenesis in developing rodent teeth.

Authors:  Antonius L J J Bronckers; Jing Guo; Behrouz Zandieh-Doulabi; Theodore J Bervoets; Donacian M Lyaruu; Xiangming Li; Philine Wangemann; Pamela DenBesten
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

6.  A motif of eleven amino acids is a structural adaptation that facilitates motor capability of eutherian prestin.

Authors:  Xiaodong Tan; Jason L Pecka; Jie Tang; Sándor Lovas; Kirk W Beisel; David Z Z He
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

7.  Functional characterization of pendrin mutations found in the Israeli and Palestinian populations.

Authors:  Silvia Dossena; Charity Nofziger; Zippora Brownstein; Moien Kanaan; Karen B Avraham; Markus Paulmichl
Journal:  Cell Physiol Biochem       Date:  2011-11-18

Review 8.  Integration of human and mouse genetics reveals pendrin function in hearing and deafness.

Authors:  Amiel A Dror; Zippora Brownstein; Karen B Avraham
Journal:  Cell Physiol Biochem       Date:  2011-11-18

Review 9.  Transcriptional regulation of the pendrin gene.

Authors:  Julia Rozenfeld; Edna Efrati; Lior Adler; Osnat Tal; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2011-11-16

Review 10.  Prestin at year 14: progress and prospect.

Authors:  David Z Z He; Sándor Lovas; Yu Ai; Yi Li; Kirk W Beisel
Journal:  Hear Res       Date:  2013-12-17       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.